Mitochondrial Dysfunction and Multiple Sclerosis

In recent years, several studies have examined the potential associations between mitochondrial dysfunction and neurodegenerative diseases such as multiple sclerosis (MS), Parkinson’s disease and Alzheimer’s disease. In MS, neurological disability results from inflammation, demyelination, and ultima...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Biology (Basel, Switzerland) Ročník 8; číslo 2; s. 37
Hlavní autori: Barcelos, Isabella Peixoto de, Troxell, Regina M., Graves, Jennifer S.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland MDPI AG 11.05.2019
MDPI
Predmet:
Alzheimer's disease
Apoptosis
Atrophy
Bioenergetics
Central nervous system
Cytokines
Demyelination
Electron transport
electron transport chain
energy
Genomes
Inflammation
ion channels
Mitochondria
Mitochondrial DNA
Movement disorders
Multiple sclerosis
Neurodegeneration
Neurodegenerative diseases
neuroinflammation
Neurological complications
Neurons
Oxidative stress
Parkinson's disease
Phosphorylation
Review
sclerosis
therapeutics
Tumor necrosis factor-TNF
neurodegeneration
neuroinflammation
mitochondria
multiple sclerosis
ISSN:2079-7737, 2079-7737
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:In recent years, several studies have examined the potential associations between mitochondrial dysfunction and neurodegenerative diseases such as multiple sclerosis (MS), Parkinson’s disease and Alzheimer’s disease. In MS, neurological disability results from inflammation, demyelination, and ultimately, axonal damage within the central nervous system. The sustained inflammatory phase of the disease leads to ion channel changes and chronic oxidative stress. Several independent investigations have demonstrated mitochondrial respiratory chain deficiency in MS, as well as abnormalities in mitochondrial transport. These processes create an energy imbalance and contribute to a parallel process of progressive neurodegeneration and irreversible disability. The potential roles of mitochondria in neurodegeneration are reviewed. An overview of mitochondrial diseases that may overlap with MS are also discussed, as well as possible therapeutic targets for the treatment of MS and other neurodegenerative conditions.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2079-7737
2079-7737
DOI:10.3390/biology8020037